DALLAS JAYSON DONALD ALEXANDER (President and CEO) reported 1 transaction at AIMMUNE THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 6/26/2020ACC: 0000899243-20-017779
DirectorOfficer· President and CEO
Since Nov 2018
-7.91K
Net shares
Net seller
$142.5K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
7.91K disposed
Non-Derivative Transactions1
Common Stock, $0.0001 par value
Direct
Shares
−7.91K
Price / share
$18.02
Trade value
$142.48K
% of position
6.2%
6/22/2020
126.58K→118.68K
Total
Net shares
−7.91K
Net value
-$142.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value Direct | 6/22/2020 | F · Tax Withholding | −7.91K | $18.02 | $142.48K | 6.2% | 126.58K | 118.68K |
| Total | −7.91K | -$142.48K | ||||||
Derivative Transactions0
No derivative transactions reported